Lidocaïnehydrochloride 20 Mg/Ml, Injectievloeistof

Lidocaine Hydrochloride, the active ingredient in Lidocaïnehydrochloride 20 Mg/Ml, Injectievloeistof, is a local anesthetic (amide) presented as a 20 mg/mL injectable solution for intravenous use. It provides local anesthesia for minor surgical procedures, regional nerve blocks, and can be used in the management of ventricular arrhythmias.

GNH USA supplies Lidocaïnehydrochloride 20 Mg/Ml, Injectievloeistof as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Lidocaine Hydrochloride is a local anesthetic used to block nerve conduction in various clinical settings.

- Minor surgical procedures: provides rapid onset local anesthesia for incision and minor tissue manipulation. - Regional nerve blocks: enables targeted anesthesia for limb or trunk procedures via peripheral nerve blockade. - Ventricular arrhythmias: used intravenously to suppress ventricular ectopic activity during cardiac emergencies.

Lidocaine Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site - Mild hypotension - Dizziness - Metallic taste - Nausea - Headache

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Cardiac conduction disturbances such as bradycardia or heart block - Methemoglobinemia - Central nervous system toxicity including seizures or loss of consciousness - Persistent numbness beyond the expected duration - Respiratory depression

Before administering Lidocaine Hydrochloride, clinicians should consider several safety measures.

- Patient assessment: evaluate cardiac history and allergy status prior to use. - Dose adjustment: use caution in patients with hepatic impairment or existing heart block. - Monitoring: observe cardiovascular and central nervous system parameters during and after injection. - Drug interactions: avoid concurrent use with class I antiarrhythmics or other local anesthetics. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lidocaine Hydrochloride can interact with several medicines, requiring attention to avoid toxicity.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase cardiotoxicity. - Other amide local anesthetics: additive risk of systemic toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardic effects. - Diuretics: may potentiate hypotension. - Calcium channel blockers: may affect cardiac conduction when combined with lidocaine.